| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2017/09/13 | 22 : 40 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/09/13 | 22 : 34 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/09/07 | 21 : 51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/08/09 | 21 : 48 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/08/09 | 21 : 21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/07/25 | 06 : 21 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/30 | 06 : 00 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/30 | 05 : 52 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/13 | 05 : 21 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 39 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/09 | 23 : 31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/06 | 19 : 04 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/03 | 06 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/02 | 05 : 15 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/06/02 | 05 : 11 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/31 | 00 : 51 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/27 | 07 : 55 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/27 | 07 : 47 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/12 | 05 : 31 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/10 | 19 : 06 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/10 | 05 : 49 | Edgar (US Regulatory) | Quarterly Report (10-q) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/09 | 00 : 28 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/04 | 01 : 53 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/01 | 22 : 08 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/05/01 | 22 : 02 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |
| 2017/04/29 | 06 : 31 | Edgar (US Regulatory) | Current Report Filing (8-k) | AMEX:MSTX | Mast Therapeutics, Inc. (delisted) |